PCN34 COST-EFFECTIVENESS OF GEFITINIB FOR FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER- A MARKOV MODEL-BASED ANALYSIS
May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70212-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)70212-6/fulltext
Section Title :
Section Order :
861
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70212-6&doi=10.1016/S1098-3015(10)70212-6